Empagliflozin MonoAcetyl Impurity
| Product Name | Empagliflozin MonoAcetyl Impurity |
|---|---|
| Alternate Names | Empagliflozin Impurities, Impurities of Empagliflozin |
| CAT No. | CS-O-12072 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 492.95 g/mol |
| Mol. For. | C₂₅H₂₉ClO₈ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Empagliflozin |
| Purity | 95% |
| Therapeutic | Anti-Diabetic |
| Smileys | O[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(C)=O)O[C@H]1C2=CC(CC3=CC=C(O[C@@H]4COCC4)C=C3)=C(Cl)C=C2 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Empagliflozin MonoAcetyl Impurity is a chemical compound that is used in the production of the diabetes medication Empagliflozin. This organic compound is classified as an impurity because it is a product of the synthesis process of the medication that is not intended to be present in the final product.
Empagliflozin MonoAcetyl Impurity is a derivative of Empagliflozin, which is an inhibitor of sodium-glucose cotransporter 2 (SGLT2) that is used to treat type 2 diabetes mellitus. The impurity is formed during the synthesis process of Empagliflozin and can be found in small amounts in the final product.
Chemically, Empagliflozin MonoAcetyl Impurity is an acetylated derivative of Empagliflozin. It has a molecular weight of 439.47 g/mol and a molecular formula of C22H24O9. The compound has a white to off-white appearance and is soluble in organic solvents like methanol and dimethyl sulfoxide.
Empagliflozin MonoAcetyl Impurity is typically removed from the final product through purification processes to ensure that the medication is safe and effective for patient use. The impurity is not intended to be present in the medication and its presence can affect the drug’s potency and safety.
Get an Instant Quote
Related Compounds
Empagliflozin Open Ring Impurity | Empagliflozin Impurity 52 | Empagliflozin Impurity II | Empagliflozin Nosyl ester hydroxy furan impurity | Empagliflozin Sugar Dimer | Empagliflozin Impurity 46 | Empagliflozin Impurity 50 | Empagliflozin Impurity 82 | Empagliflozin Diol impurity (S-Isomer) | Empagliflozin Sulfonate Impurity | Empagliflozin Impurity 2 | Empagliflozin M468 | Empagliflozin Dimer Impurity | Empagliflozin Silyl Impurity | Empagliflozin Recemic mixture | Empagliflozin Des bromomethoxy | Methoxy Empagliflozin R-Furanose | Empagliflozin Enantiomer Impurity | Empagliflozin Enantiomer Impurity | Empagliflozin Impurity POE | Empagliflozin Impurity 4 | Empagliflozin impurity D | Hydroxy empagliflozin | Empagliflozin alpha Isomer | Empagliflozin Impurity 5 | Empagliflozin R-Furanose | Empagliflozin Impurity 40 | Empagliflozin Nosyl impurity | Empagliflozin Intermediate-A | Empagliflozin Destetrahydrofuran Impurity | Empagliflozin Impurity 26 | Empagliflozin Iodo R-furan impurity | Empagliflozin L- Glucono Diastereomer | Empagliflozin M464 | Empagliflozin Impurity E | Empagliflozin Iodo impurity | Empagliflozin Impurity 62 | DIMETHOXY EMPAGLIFLOZIN | Empagliflozin Acetyl impurity | Empagliflozin impurity A | Empagliflozin S-Furanose | Empagliflozin Methoxy impurity | Empagliflozin Methoxy Intermediate | O-Destetrahydrofuran O-Pentaacetyl Empagliflozin | Empagliflozin Bromo Impurity | Empagliflozin impurity B | Empagliflozin Methyl Acetate | Empagliflozin impurity C | Empagliflozin Dichloro impurity |